{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04129320: Phase 2/Phase 3 Interventional Withdrawn Head and Neck Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00516217: Phase 2 Interventional Completed Lymphoma
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01710644: Phase 1/Phase 2 Interventional Completed Pancreatic Insufficiency
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03428022: Phase 3 Interventional Unknown status NSCLC
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02573324: Phase 3 Interventional Completed Glioblastoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03333824: Phase 1 Interventional Completed Solid Tumours
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tulisokibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03336606: Phase 1 Interventional Active, not recruiting Head and Neck Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02368951: Phase 1 Interventional Terminated Medical Oncology
(2015)
Source URL:
Class:
PROTEIN
